According to the recently published report by Informes de Expertos, titled “Mercado Latinoamericanode InyectablesGenéricos,Informe y Pronóstico 2021-2026”, it is anticipated that the generic injectables market in Latin America will grow at a CAGR of around X% during 2021-2026. Increasing prevalence of chronic diseases and the growing demand for patients undergoing chemotherapy are some of the growth-inducing factors. Rising geriatric population, R&D activities, increasing patent expirations, and innovation and the launch of improved products by key companiesare further responsible for the development of the market.